News Room
News Releases
-
- Mar. 13, 2023 (PDF/217KB)Corporate
-
Sumitomo Pharma, Sumitovant Biopharma, and Myovant Sciences Complete the Transaction
-
- Mar. 06, 2023 (PDF/123KB)Licensing
-
KYORIN and Sumitomo Pharma Enter into License Agreement of Vibegron in Taiwan and Other Asian Countries
-
- Mar. 03, 2023 (PDF/164KB)Finances
-
Announcement on Impairment Loss and Revision of Dividend Forecast
-
- Mar. 02, 2023 (PDF/197KB)Corporate
-
Sumitomo Pharma Announces Organizational Realignment and Changes in the Positions Assumed by Executive Officers and Other Key Positions
-
- Feb. 22, 2023 (PDF/170KB)Sustainability
-
Sumitomo Pharma Announces Contributes to the Relief Efforts for the Earthquake in Turkey and Syria
-
- Feb. 07, 2023Finances
-
Posted Conference Call for Q3 FY2022 [Webcast]
-
- Jan. 31, 2023 (PDF/438KB)Finances
-
Presentation Material(Third Quarter Financial Results for FY2022)
-
- Jan. 31, 2023 (PDF/451KB)Finances
-
Supplementary Financial Data (IFRS) for the Third Quarter of the Year Ending March 31, 2023
-
- Jan. 31, 2023 (PDF/509KB)Finances
-
Summary of Consolidated Financial Results for the Third Quarter of the Year Ending March 31, 2023 [IFRS]
-
- Jan. 31, 2023 (PDF/200KB)Finances
-
Sumitomo Pharma Announces Revisions to Its Financial Forecasts
Documents for Press
-
- Nov. 01, 2019 (PDF/1,557KB)Corporate
-
Press Conference Presentation for Definitive Agreement for Strategic Alliance with Roivant Sciences
-
- Oct. 28, 2019 (PDF/926KB)Finances
-
Press Conference Presentation for Q2 FY2019 (April 1 to September 30, 2019)
-
- Dec. 02, 2013 (PDF/414KB)R&D
-
Presentation material of press conference (Healios and DSP: Alliance for Japanese market-iPS cell technology into practical use-)